Life Sciences Attorney Thomas Duley Joins DLA Piper
Addition Brings Industry Experience; Strengthens Firm’s Leading Life Sciences Capabilities
(San Francisco) March 23, 2010 – DLA Piper announced today that Thomas E. Duley has joined the firm as of counsel in the Corporate and Securities practice. He will be located in the firm’s San Francisco and Palo Alto offices.
Duley, former senior corporate counsel and head of the transactional legal group at PDL BioPharma, Inc., focuses his practice on negotiating, drafting and managing a variety of intellectual property transactions for life sciences companies, including collaboration agreements between biotechnology and pharmaceutical companies, licensing agreements with commercial businesses and academic institutions, supply and manufacturing agreements, and asset purchases and sales involving drug products and manufacturing facilities.
“We are pleased to be able to add someone with Tom’s extraordinary experience in the life sciences industry, both as an in-house lawyer and as a private lawyer, to our life sciences team,” said Bruce W. Jenett, co-chair of DLA Piper’s Global Life Sciences Sector. “DLA Piper already has a leading life sciences practice and Tom brings significant new and valuable capabilities for our clients not only in the Bay Area, but also nationally and internationally.”
“Tom brings a wealth of industry-specific experience to the firm, a quality that is especially vital in the life sciences industry,” added Howard Clowes, a partner in the firm’s Silicon Valley office and head of DLA Piper’s Northern California Corporate practice. “In particular, his deep knowledge and understanding of, and his experience with, development and commercial deals in the life sciences industry will provide a tremendous resource to our clients. We are delighted to welcome him to the firm.”
A Global Life Sciences Practice
Providing clients with a truly global life sciences practice, DLA Piper’s firmwide team has significant experience representing leading private and public life sciences companies, and leading investors, including venture capital firms, entrepreneurs and financial institutions, as well as some of the leading nonprofit institutions in the US and worldwide. The firm advises clients in all stages of growth, from start-ups to Fortune 500 companies, in all areas of the industry, including therapeutics, diagnostics and bioinformatics, medical devices, bioengineering, nanotechnology, and bioagriculture, as well as leading clients in the healthcare industry.
Duley’s arrival, along with the recent arrival of corporate partner Curtis Mo, and of the healthcare team of Stephen Goff and his colleagues in the firm’s healthcare practice, represents the latest move in the continued expansion of DLA Piper’s global life sciences and corporate and finance practices, the latter of which includes more than 800 attorneys worldwide. DLA Piper is recognized as one of the most active firms in the global venture capital and private equity arena.
About Thomas E. Duley
Prior to joining DLA Piper, Duley was of counsel in Morgan, Lewis & Bockius LLP’s Business and Finance Practice.
At PDL BioPharma, Inc., a publicly traded biopharmaceutical company that researches, develops, manufactures, and sells pharmaceutical products, Duley was responsible for all general commercial and intellectual property contracts on behalf of the organization, including managing legal issues arising from collaborations with pharmaceutical and biotechnology companies.
He has overseen real estate and construction contracts and guided and implemented formal contracting policies in compliance with Sarbanes-Oxley regulations. He is also a licensed architect, with experience in designing laboratories.
Duley received a J.D. from the University of California, Davis School of Law, and an M. Arch. and a B.A. from the University of California, Los Angeles.
About DLA Piper (www.dlapiper.com)
DLA Piper has 3,500 lawyers in 29 countries and 67 offices throughout the US, UK, Continental Europe, Middle East and Asia. In certain jurisdictions, this information may be considered attorney advertising.
###
CONTACTS:
Jason Costa, Media Relations, DLA Piper, 212.776.3739
Kristen Griffin, Media Relations, Greentarget Global Group, 312.252.4107
